Sigma-Aldrich
Life Science

Antibody Explorer
Automation
Cancer Research
Cell Culture
Cell Signaling
Product Lines
Product Highlights
Anti-Glutamate NR1
Antibodies to HDAC
Fluorescent Probes
Isradipine
MRS 2395
Monoclonal Anti g Parvin
Monoclonal Anti-D1
Receptor Preparations
SB-431542
XK469
nNOS Inhibitors
Previous Highlights
New Literature
Celltransmissions News
Key Resources
Custom Synthesis
Drug Discovery
Functional Genomics and RNAi
Molecular Biology
Nutrition Research
Obesity Research
Plant Biotechnology
Proteomics and Protein Expr.
Stable Isotopes
Life Science Quarterly

 ABT-418
Cell Signaling & Neuroscience
 

A novel neuronal nicotinic acetylcholine receptor agonist with cognition enhancing and anxiolytic activities.

Prod. No. A 6476

Nicotinic acetylcholine receptors (nAChRs) are a family of ligand-gated cation channels that are activated by the alkaloid (–)-nicotine (Prod. No. N3876) and are classified on the basis of their subunit structure [1]. Ten a (a1- a10) and four b ( b1-b4) subunits have been cloned from mammalian and avian sources. Additional g, d and e subunits are associated with nAChRs present at the neuromuscular junction [1-3]. Until recently, few selective ligands have been widely available with which to study nAChRs. Such compounds include the sedative a4b2 antagonist dihydro-b -erythroidine (Prod. No. D-149) and the selective a7 antagonists methyllycaconitine
(Prod. No. M-168) and MG-264 (Prod. No. M3184).

Sigma-RBI is pleased to introduce ABT 418 (Prod. No. A6476) as a novel bioisostere of (–)- nicotine that is a full agonist at the a4b2 neuronal nAChR, which is a predominant form of nAChR in the central nervous system (CNS).

Features and Benefits:

  • Potent displacer of [3H]-cytisine binding to rat brain nAChRs (Ki = 3 nM) [3].
  • Essentially inactive (Ki > 10 µM) in a wide range of other receptor/neurotransmitter uptake/enzyme assays, including those for muscarinic and 5-HT3 serotonin receptors [3].
  • Demonstrated a reduced potency at the subunit isoforms of nAChR found in sympathetic ganglia as compared with (–)-nicotine [4,5].
  • Improved retention of inhibitory avoidance training in rodent behavioral tests, with less undesirable side effects such as emesis, hypothermia and seizures [4,5].

Physical Description:
Solubility:
Molecular Formula:
Formula Weight:
Sizes:
Solid
Soluble at 15 mg/ml in water
C9H14N2O•HCl
202.7
5 mg, 25 mg
A6476 Structure

Subject to U.S. Patent No. 5409946 and sold under license from Abbott Laboratories.

References

  1. Lukas, R.J. et al., Pharmacol. Rev., 51, 397-401 (1999).
  2. Lloyd, K.G. and Williams, M., J. Pharmacol. Exp. Ther., 292, 461-467 (2000).
  3. Dani, J.A., Biol. Psychiatry, 49, 166-174 (2001).
  4. Decker, M.W. et al., J. Pharmacol. Exp. Ther., 270, 319-328 (1994).
  5. Brioni, J.D. et al., J. Pharmacol. Exp. Ther., 271, 353-361 (1994).

To order, please call 800-325-3010 or Fax 800-325-5052 or contact your local Sigma-Aldrich sales office. On-line ordering is not yet available for this product.

ABT 418 is featured in Celltransmissions Volume 19, No. 1. Click here to see article.

Back to Cell Signaling Home